| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |